Jane Street Group LLC Decreases Holdings in Chemed Co. (NYSE:CHE)

Jane Street Group LLC cut its holdings in Chemed Co. (NYSE:CHE - Free Report) by 56.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,245 shares of the company's stock after selling 6,913 shares during the period. Jane Street Group LLC's holdings in Chemed were worth $3,152,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CHE. HighTower Advisors LLC lifted its position in shares of Chemed by 78.0% during the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company's stock worth $2,246,000 after buying an additional 1,634 shares during the last quarter. Hsbc Holdings PLC grew its holdings in shares of Chemed by 110.0% during the 2nd quarter. Hsbc Holdings PLC now owns 10,638 shares of the company's stock valued at $5,801,000 after purchasing an additional 5,572 shares during the last quarter. Evergreen Capital Management LLC bought a new position in Chemed in the 2nd quarter valued at approximately $7,812,000. Quest Partners LLC boosted its position in Chemed by 634.3% in the second quarter. Quest Partners LLC now owns 1,990 shares of the company's stock valued at $1,080,000 after buying an additional 1,719 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its position in Chemed by 1.5% in the second quarter. Envestnet Asset Management Inc. now owns 74,461 shares of the company's stock valued at $40,401,000 after buying an additional 1,106 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently issued reports on CHE shares. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th. Royal Bank of Canada cut their price target on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a report on Tuesday, November 5th.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the transaction, the chief executive officer now directly owns 103,735 shares of the company's stock, valued at approximately $62,117,555.35. This represents a 1.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the firm's stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the sale, the executive vice president now directly owns 18,287 shares of the company's stock, valued at $10,526,362.94. This trade represents a 3.85 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 5,132 shares of company stock worth $3,003,502. 3.32% of the stock is owned by corporate insiders.

Chemed Trading Up 0.3 %

CHE stock traded up $1.37 during trading on Friday, hitting $523.16. The company had a trading volume of 241,923 shares, compared to its average volume of 87,427. Chemed Co. has a one year low of $516.91 and a one year high of $654.62. The business has a 50-day moving average of $564.38 and a 200-day moving average of $563.89. The stock has a market cap of $7.87 billion, a PE ratio of 26.44, a PEG ratio of 2.32 and a beta of 0.46.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company's quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the company earned $5.32 earnings per share. Research analysts forecast that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were paid a dividend of $0.50 per share. The ex-dividend date was Monday, November 18th. This represents a $2.00 annualized dividend and a yield of 0.38%. Chemed's dividend payout ratio is currently 10.11%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.